The COMET (Comparison of Operative Versus Monitoring and Endocrine Therapy) Trial: A Phase III Randomised Controlled Clinical Trial for Low-Risk Ductal Carcinoma in Situ (DCIS)

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2018-026797